Advertisement
Advertise Here
-
October 11, 2010 - Volume 88, Number 41
- p. 9
- Article Appeared Online October 8, 2010
Forensic Chemistry: A new method could increase the number of explosives detected by airport screeners.
Trade: U.S. companies complain of market dumping by China.
Layoffs follow similar moves by Amgen, AstraZeneca.
Environment: Ban to halt export of hazardous waste to developing world.
Penrose (Parney) Albright will direct DOE national lab.
Toxic Exposure: Mercury isotopes in human hair illuminate dietary and industrial sources.
Cancer Biochemistry: Mass spectrometry follows the metabolism of very long fatty acids in cancer cells.
The development of in vitro fertilization (IVF), an infertility treatment in which an egg is fertilized by sperm outside the human body and later implanted into a woman’s uterus so she becomes pregnant, has garnered Robert G. Edwards, a professor emeritus at the University of Cambridge, the 2010 Nobel Prize in Physiology or Medicine. The honor comes with $1.5 million in prize money.
Edwards’ “achievements have made it possible to treat infertility, a medical condition afflicting a large proportion of humanity, including more than 10% of all couples worldwide,” the Nobel Prize announcement says. Edwards, 85, is also a founder of the Bourn Hall Clinic, a center for IVF treatment in Cambridge, England.
At a press conference in Sweden, Göran K. Hansson, secretary of the Nobel Prize committee, said Edwards is in poor health, so news of his award was communicated by telephone to his wife, “who said she was delighted and was sure he would also be delighted.”
On July 25, 1978, the first baby was born through IVF treatment. This year, approximately 4 million babies will be born from the procedure.
“Every clinician in the field of reproductive medicine worldwide will celebrate,” says Enda McVeigh, the medical director of Oxford University Fertility Unit. “IVF changed millions of people’s lives and continues to give hope to so many couples. IVF has also opened doors in new areas: preimplantation genetic diagnosis and stem cells, to name but two.”
The pursuit of IVF “was not easy for Edwards,” McVeigh adds. “At the start of his research, he was not supported by the ‘establishment’ in the U.K.” For example, the U.K.’s Medical Research Council discontinued funding of his research. Some ethicists, certain religious groups, and parts of the media lobbied against his research.
“I had to issue eight libel actions in the High Court of London on a single day,” wrote Edwards in a 2001 article in Nature Medicine (7, 1091). “I won them all, but the work and worry restricted research for several years.”
ACS is the leading employment source for recruiting scientific professionals. ACS Careers and C&EN Classifieds provide employers direct access to scientific talent both in print and online. Jobseekers | Employers
Join more than 161,000 professionals in the chemical sciences world-wide, as a member of the American Chemical Society.
» Join Now!